Evidence map›Paper›PMID 33331608›Full record

ArticleRevista da Sociedade Brasileira de Medicina Tropical2020

Monitoring HIV infection in Minas Gerais state: 15-year assessment of adults living with HIV initiating Antiretroviral Therapy.

Cássia Cristina Pinto Mendicino, Gabriella Jomara da Silva, Letícia Penna Braga, Enrico Antônio Colosimo, Mark Drew Crosland Guimarães, Cristiane Aparecida Menezes de Pádua

Abstract read
In one paragraph

Article in Revista da Sociedade Brasileira de Medicina Tropical, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cássia Cristina Pinto MendicinoUniversidade Federal de Minas Gerais, Faculdade de Farmácia, Programa de Pós-Graduação Stricto Sensu em Medicamentos e Assistência Farmacêutica, Belo Horizonte, MG, Brasil.ORCID http://orcid.org/0000-0002-1627-292X
Gabriella Jomara da SilvaUniversidade Federal de Minas Gerais, Faculdade de Medicina, Programa de Pós-graduação Stricto Sensu em Infectologia e Medicina Tropical, Belo Horizonte, MG, Brasil.
Letícia Penna BragaFundação Oswaldo Cruz, Escola Nacional de Saúde Pública, Programa Stricto Sensu de Pós-graduação em Epidemiologia em Saúde Pública, Rio de Janeiro, RJ, Brasil.
Enrico Antônio ColosimoUniversidade Federal de Minas Gerais, Instituto de Ciências Exatas, Departamento de Estatística, Belo Horizonte, MG, Brasil.
Mark Drew Crosland GuimarãesUniversidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
Cristiane Aparecida Menezes de PáduaUniversidade Federal de Minas Gerais, Faculdade de Farmácia, Programa de Pós-Graduação Stricto Sensu em Medicamentos e Assistência Farmacêutica, Belo Horizonte, MG, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe first Brazilian HIV treatment recommendation was put forward in 1996, resulting in 12 subsequent guidelines. Several changes were made regarding "when" and "how" to begin treatment. The latest guideline recommends immediate initiation of antiretroviral therapy (ART). This study aimed to describe the evolution of HIV treatment among people living with HIV (PLHIV) who initiated ART between 2004 and 2018 based on the national guideline recommendations concerning T-CD4+ and VL measurements.

methodsA cross-sectional analysis of data of PLHIV aged >18 years, in Minas Gerais who received ART between 2004 and 2018 was conducted. Clinical, therapeutic, and demographic information were obtained from national healthcare databases. The study was divided into four periods: 2004-2007, 2008-2012, 2013-2016, and 2017-2018. Descriptive analyses were performed.

resultsA total of 60,618 PLHIV initiated ART (67% male and 48% aged 25-39 years), 36% of whom had CD4 counts at ART initiation and 51% documented VL after ART initiation. The median CD4 count ranged from 288 to 373 cells/µL. The median time to ART initiation decreased from 604 to 28 days and was lower among males (p <0.01). The median time from ART initiation to the first VL result decreased from 101 to 62 days over the study period, while the median VL after ART initiation ranged from 2.3 to 1.7 log10 copies/ml.

conclusionsAlthough our results demonstrated that most recommendations were followed, there seemed to be little impact on CD4 counts and VL testing. This may result in an inadequate evaluation of ART effectiveness.

Indexed as

Anti-HIV AgentsHIV InfectionsAdolescentAdultBrazilCD4 Lymphocyte CountCross-Sectional StudiesFemaleHumansMaleViral LoadAnti-HIV Agents

Identifiers

PMID33331608
PMCPMC7747810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.